Indefinite Delivery Contract SPE2DV17D2040

This indefinite delivery contract (IDC) was awarded by the Defense Logistics Agency (DLA) to Cardinal Health 200, LLC, a subsidiary of Cardinal Health, Inc. The single-award IDC has a ceiling value of $4,999,999 and a period of performance through June 7, 2027. It is intended to provide a flexible procurement mechanism for the DLA and other Department of Defense (DoD) customers to rapidly acquire a wide range of medical supplies under Federal Supply Group 46 and Federal Supply Class 6515. These include surgical dressings, drugs, biologicals, medical consumables, and specialized medical equipment. The contract enables the government to issue multiple delivery orders against the master IDC to support military treatment facilities and other DoD healthcare providers. Cardinal Health 200, LLC, as a major healthcare services and products company, has demonstrated its ability to supply a diverse portfolio of essential medical items to federal agencies, particularly within the military healthcare system. The IDC underscores the company's strategic importance in maintaining the medical supply chain for the DoD and highlights its role as a critical vendor in the federal healthcare supply network.

In addition to the single-award IDC with the DLA, Cardinal Health, Inc. and its subsidiaries hold several other significant federal contract vehicles. These include a $773,677.24 IDV with the Department of Veterans Affairs (VA) specifically for the provision of radiopharmaceutical products to support medical imaging procedures in the VA healthcare system, as well as a $10,056,938.10 single-award IDC held by the company's subsidiary, The Harvard Drug Group, L.L.C., for the supply of Lurasidone Hydrochloride tablets to the VA National Acquisition Center. These contract awards demonstrate Cardinal Health's specialized capabilities in handling and distributing time-sensitive, radioactive medical products and its ability to manage large-scale, multi-agency pharmaceutical supply agreements.